Each drop of blood carries billions of messages with critical information.
This wealth of information is transmitted throughout our bodies via the bloodstream using a complex extracellular vesicle messaging system.
It is a monumental challenge to detect and decipher these messages to better diagnose and manage the treatment of disease.
Our core technology can read and decipher information from millions of particles in a single drop of blood with unprecedented accuracy.
Our non-invasive and cost-effective technology combines advanced microflow cytometry with sophisticated machine learning algorithms and is currently in developmental trials to provide more timely and accurate information that can be used to better understand disease.
Our novel technology is applicable to a wide range of diseases, including prostate, brain,
pancreatic and blood cancers as well as cardiovascular and neuro-degenerative diseases.
Our bodies use tiny messengers, called extracellular vesicles, to communicate throughout the body. At Nanostics we are developing a novel technology that deciphers these messages to diagnose disease better–we are creating a new test that more accurately diagnoses clinically significant prostate cancer from a few drops of blood.